[Unusual but serious adverse effect. Epoetin treatment of patients with kidney diseases caused erythroblastopenia].
Stenvinkel
Peter
P
Njurmedicinska kliniken, Huddinge Universitetssjukhus. peter.stenvinkel@klinvet.ki.se
Bárány
Peter
P
D000906:Antibodies / Q000032:analysis; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000276:immunology; D017467:Receptors, Erythropoietin / Q000276:immunology; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*
D000906:Antibodies; D017467:Receptors, Erythropoietin; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa